Quarterly Result30 May 2026, 09:38 pm
TTK Healthcare: FY26 Audited Results, ₹10 Dividend Recommended
AI Summary
TTK Healthcare Ltd. announced the audited financial results for the fourth quarter and year ended March 31, 2026. The Board of Directors recommended a dividend of ₹10 per equity share (100%) subject to shareholder approval. The board approved the reappointment of Mr. T T Raghunathan as Executive Chairman for a further term of 5 years and the appointment of M/s Geeyes & Co. as the Cost Auditor for FY 2026-27. The 68th Annual General Meeting is scheduled for July 24, 2026, via video conferencing.
Key Highlights
- Approved audited financial results for Q4 and year ended March 31, 2026.
- Recommended a dividend of ₹10 per equity share (100%) for FY26.
- Reappointed Mr. T T Raghunathan as Executive Chairman for 5 years.
- Appointed M/s Geeyes & Co. as Cost Auditor for FY 2026-27.
- 68th AGM scheduled for July 24, 2026, via video conferencing.
Price Impact
More from TTKHEALTH